BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33388881)

  • 41. MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1.
    Ning ZW; Luo XY; Wang GZ; Li Y; Pan MX; Yang RQ; Ling XG; Huang S; Ma XX; Jin SY; Wang D; Li X
    Antioxid Redox Signal; 2017 Jul; 27(1):1-20. PubMed ID: 27502441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
    Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury.
    Frissen M; Liao L; Schneider KM; Djudjaj S; Haybaeck J; Wree A; Rolle-Kampczyk U; von Bergen M; Latz E; Boor P; Trautwein C
    Hepatology; 2021 May; 73(5):1836-1854. PubMed ID: 32748971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the NLRP3 inflammasome in microglia: the role of ceramide.
    Scheiblich H; Schlütter A; Golenbock DT; Latz E; Martinez-Martinez P; Heneka MT
    J Neurochem; 2017 Dec; 143(5):534-550. PubMed ID: 28940479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
    Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.
    Yang J; Tang X; Liang Z; Chen M; Sun L
    Clin Mol Hepatol; 2023 Apr; 29(2):465-481. PubMed ID: 36800698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigallocatechin gallate (EGCG) attenuates staphylococcal alpha-hemolysin (Hla)-induced NLRP3 inflammasome activation via ROS-MAPK pathways and EGCG-Hla interactions.
    Liu C; Hao K; Liu Z; Liu Z; Guo N
    Int Immunopharmacol; 2021 Nov; 100():108170. PubMed ID: 34562843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S1P/S1P
    Lee CH; Choi JW
    Antioxidants (Basel); 2021 Oct; 10(11):. PubMed ID: 34829577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Luxeptinib disables NLRP3 inflammasome-mediated IL-1β release and pathways required for secretion of inflammatory cytokines IL-6 and TNFα.
    Sonowal H; Zhang H; Rice W; Howell SB
    Biochem Pharmacol; 2022 Jan; 195():114861. PubMed ID: 34843717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.
    Li D; Li C; Wang T; Zhang C; Zhu Z; Zhang G; Fang B
    Int Immunopharmacol; 2021 Nov; 100():108106. PubMed ID: 34530204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury.
    Li D; Ren W; Jiang Z; Zhu L
    Mol Med Rep; 2018 Nov; 18(5):4399-4409. PubMed ID: 30152849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.
    Orr Gandy KA; Adada M; Canals D; Carroll B; Roddy P; Hannun YA; Obeid LM
    FASEB J; 2013 Aug; 27(8):3155-66. PubMed ID: 23629860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pin1 Promotes NLRP3 Inflammasome Activation by Phosphorylation of p38 MAPK Pathway in Septic Shock.
    Dong R; Xue Z; Fan G; Zhang N; Wang C; Li G; Da Y
    Front Immunol; 2021; 12():620238. PubMed ID: 33717117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NLRP3 Inflammasome Activation Is Involved in LPA
    Lee CH; Sapkota A; Gaire BP; Choi JW
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts.
    Higashi K; Matsuzaki E; Hashimoto Y; Takahashi-Yanaga F; Takano A; Anan H; Hirata M; Nishimura F
    Bone; 2016 Dec; 93():1-11. PubMed ID: 27612439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
    Völzke A; Koch A; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2014 Jan; 1841(1):11-21. PubMed ID: 24064301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. All-Trans Retinoic Acid Enhances both the Signaling for Priming and the Glycolysis for Activation of NLRP3 Inflammasome in Human Macrophage.
    Alatshan A; Kovács GE; Aladdin A; Czimmerer Z; Tar K; Benkő S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
    Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
    J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophage priming is dispensable for NLRP3 inflammasome activation and restriction of Leishmania amazonensis replication.
    de Carvalho RVH; Silva ALN; Santos LL; Andrade WA; de Sá KSG; Zamboni DS
    J Leukoc Biol; 2019 Sep; 106(3):631-640. PubMed ID: 31063608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.